Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome–positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study
Adrienne de Labarthe(Hôpital Saint-Louis), Hervé Dombret(University of London Institute in Paris), Arnaud Pigneux(Centre Hospitalier Universitaire de Bordeaux), Agnès Buzyn(Hôpital Saint-Jacques), Véronique Lhéritier(Hospices Civils de Lyon), Éric Delabesse(Hôpital Necker-Enfants Malades), Sébastien Maury(Assistance Publique – Hôpitaux de Paris), Francis Witz(Centre Hospitalier Régional et Universitaire de Nancy), Norbert Ifrah(Institut National du Cancer), Philippe Rousselot(Université Paris-Saclay), Delphine Réa(Institut Bergonié), Elizabeth Macintyre(Inserm), Xavier Thomas(Hôpital Lyon Sud), Yves Chalandon(University of Geneva), Jean‐Michel Cayuela(Inserm), Françoise Huguet‐Rigal(Hôpital Nord), Marie-Christine Vekemans(Cliniques Universitaires Saint-Luc), Oumédaly Reman(Centre Hospitalier Universitaire de Caen), Jean‐Paul Vernant(Hôpital Saint-Jacques), Martine Escoffre(Institute Cancer De La Loire Lucien Neuwirth)
Cited by 345
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k